Rituximab:: Ongoing and future clinical development

被引：132

作者：

Grillo-López, AJ

Hedrick, E

Rashford, M

Benyunes, M

机构：

[1] Genentech Inc, Genentech Biooncol, Ctr Oncol, San Francisco, CA 94080 USA

[2] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期

关键词：

D O I：

10.1053/sonc.2002.30145

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：105 / 112

页数：8

共 27 条

[1] Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma [J].

Anderson, DR ;

GrilloLopez, A ;

Varns, C ;

Chambers, KS ;

Hanna, N .

BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) :705-708

[2] PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA [J].

ANHALT, GJ ;

KIM, S ;

STANLEY, JR ;

KORMAN, NJ ;

JABS, DA ;

KORY, M ;

IZUMI, H ;

RATRIE, H ;

MUTASIM, D ;

ARISSABDO, L ;

LABIB, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1729-1735

[3] Overview of idiopathic thrombocytopenic purpura: New approach to refractory patients [J].

Bussel, JB .

SEMINARS IN ONCOLOGY, 2000, 27 (06) :91-98

[4]

Byrd JC, 2000, BLOOD, V96, p837A

[5]

Coiffier B, 2000, BLOOD, V96, p223A

[6]

Czuczman M, 1999, BLOOD, V94, p99A

[7] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[8] Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma:: Results of a phase II trial of rituximab [J].

Davis, TA ;

White, CA ;

Grillo-López, AJ ;

Velásquez, WS ;

Link, B ;

Maloney, DG ;

Dillman, RO ;

Williams, ME ;

Mohrbacher, A ;

Weaver, R ;

Dowden, S ;

Levy, R .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1851-1857

[9] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment [J].

Davis, TA ;

Grillo-López, AJ ;

White, CA ;

McLaughlin, P ;

Czuczman, MS ;

Link, BK ;

Maloney, DG ;

Weaver, RL ;

Rosenberg, J ;

Levy, R .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3135-3143

[10] Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes [J].

Edwards, JCW ;

Cambridge, G .

RHEUMATOLOGY, 2001, 40 (02) :205-211

← 1 2 3 →